CD274 and neoplasm: In this study, we initiated a novel combination of immunotherapy and chemotherapy for cancer by decorating a chemotherapeutics-loaded nanoparticle with PD-1/PD-L1 antagonist-DPPA-1 peptide and tumor angiogenesis targeting peptide CGKRK.